Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Crossref DOI link: https://doi.org/10.1038/s41392-022-01200-x
Published Online: 2022-10-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niu, Zhenyi
Jin, Runsen
Zhang, Yan
Li, Hecheng
Text and Data Mining valid from 2022-10-05
Version of Record valid from 2022-10-05
Article History
Received: 1 June 2022
Revised: 3 September 2022
Accepted: 18 September 2022
First Online: 5 October 2022
Competing interests
: The authors declare no competing interests.